Oral-Systemic Link: Page 82

Nicotine lozenges, tobacco-free snuff help users quit
By DrBicuspid.com staff writers
Smokeless tobacco users who said they didn't want to quit changed their minds or significantly cut back their use when given nicotine lozenges or tobacco-free snuff in a Mayo Clinic study, published in Addictive Behaviors (February 4, 2013).
February 20, 2013
Drug combo could prevent head/neck cancer in high-risk patients
By DrBicuspid.com staff writers
Researchers have found promising results from a drug combination that appears to reduce the risk for patients with advanced oral precancerous lesions to develop squamous cell carcinoma of the head and neck (SCCHN), according to a new study published in Clinical Cancer Research.
February 20, 2013
Ancient teeth bacteria reveal oral disease evolution
By DrBicuspid.com staff writers
DNA preserved in calcified bacteria on the teeth of ancient human skeletons has shed light on the health consequences of the evolving diet and behavior from the Stone Age to the present (Nature Genetics, February 17, 2013).
February 18, 2013
Free oral cancer screenings offered at Midwinter Meeting
By DrBicuspid.com staff writers
DentalEZ Group is teaming up with Henry Schein and the Oral Cancer Foundation to provide free oral cancer screenings at this year's Chicago Midwinter Dental Meeting.
February 18, 2013
Ky. cancer center emphasizes patients' quality of life
By Donna Domino
A University of Louisville cancer center's multidisciplinary approach for patients with head and neck cancers utilizes a number of novel techniques to decrease the debilitating side effects of radiation and chemotherapy. The center also conducts research and clinical trials for targeted therapies that aim to restore patients' oral functions.
February 18, 2013
2013 02 19 10 27 34 729 Khan Zafrulla 70
Test article
A cancer treatment center in Portland, OR, has created a unique multidisciplinary treatment program for patients with oral and head and neck cancers. The coordinated approach is seen as a better way to treat these patients, who often need expensive and complex dental rehabilitation
February 17, 2013
Survey finds slim link between obesity, periodontitis
By Rosemary Frei, MSc
TORONTO - The findings from a recent Canadian health survey did not reveal a significant association between obesity and periodontitis -- despite the fact that previous studies found at least a 35% increased risk for periodontitis among obese individuals.
February 14, 2013
2009 11 03 11 05 21 606 Obesity 70
Feb. CDA journal focuses on salivary diagnostics
By DrBicuspid.com staff writers
The February Journal of the California Dental Association explores salivary diagnostics, taking a significant posture in dentistry based on its recent advancements in the basic, translational, and clinical sciences, the California Dental Association (CDA) announced.
February 12, 2013
How to help ease cancer patients' oral complications
By Donna Domino
While cancer survival rates are improving, common cancer therapies such as chemoradiation often cause acute oral complications and toxicities that are largely unavoidable, according to a study in CA: A Cancer Journal for Clinicians. The authors offer some tips to help dental care providers address these issues.
February 12, 2013
2010 12 02 00 13 58 619 Cancer Cell 70
CT texture analysis yields esophageal cancer biomarkers
By DrBicuspid.com staff writers
Computed tomography (CT) texture analysis of primary tumors may be a potential imaging biomarker in localized esophageal cancer following neoadjuvant chemotherapy, according to research presented February 9 at the 2013 Cancer Imaging and Radiation Therapy Symposium in Orlando, FL.
February 10, 2013
Obesity linked to higher risk of perio disease
By DrBicuspid.com staff writers
Obesity, which impacts roughly one-third of the U.S. population, has been linked to periodontal disease, according to an article published in the January/February 2013 issue of General Dentistry.
February 5, 2013
Soligenix targets cancer-related oral mucositis
By DrBicuspid.com staff writers
Soligenix, a development-stage biopharmaceutical company, has formed a medical advisory board to provide medical/clinical strategic guidance to the company as it advances the development of SGX942 for the treatment of oral mucositis, a common complication of cancer treatments.
February 4, 2013
Previous Page
Page 82 of 151
Next Page